Yuki Gosei Kogyo Co., Ltd. (4531) AI Stock Analysis

• Market Cap: ¥5.89B
• Dividend Yield: 3.33%
• Average Volume (3M): 38.24K
• Price to Earnings (P/E): 8.2
• Beta (1Y): 0.74
• Revenue Growth: 19.66%
• EPS Growth: -13.42%
• Country: JP
• Employees: 290
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals
• EPS (TTM): 4.46
• Shares Outstanding: 21,974,000
• 10 Day Avg. Volume: 57,840
• 30 Day Avg. Volume: 38,240
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥293.00
• Price Target Upside: 8.52% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 73 Outperform
• Price Target: ¥293.00 ▲(8.52% Upside)

The company's financial performance is strong, with consistent revenue growth and solid profitability margins. Valuation metrics suggest the stock is undervalued with an attractive dividend yield. Technical indicators show mixed signals, with the stock slightly above its short-term moving average but other indicators suggesting caution. The lack of earnings call data and notable corporate events limits additional insights.

Yuki Gosei Kogyo Co., Ltd. Business Overview & Revenue Model

Company Description

Yuki Gosei Kogyo Co., Ltd. is a Japanese chemical company specializing in the production and sale of fine chemicals and pharmaceuticals. The company operates primarily in the chemical sector, offering a diverse range of products including intermediates for pharmaceuticals, agrochemicals, and specialty chemicals. Yuki Gosei Kogyo is known for its innovative approach to chemical synthesis and its commitment to high-quality production standards.

How the Company Makes Money

Yuki Gosei Kogyo Co., Ltd. generates revenue through the manufacturing and sale of its chemical products. Its key revenue streams include the sale of pharmaceutical intermediates, which are critical components in the production of various drugs, and specialty chemicals used in industries such as agriculture and manufacturing. The company may also engage in partnerships and collaborations with other firms to enhance its product offerings and market reach. Additionally, Yuki Gosei Kogyo's focus on research and development enables it to create innovative products that meet the evolving needs of its clients, thereby sustaining its revenue growth.

Yuki Gosei Kogyo Co., Ltd. Financial Statement Overview

Summary

Yuki Gosei Kogyo Co., Ltd. shows solid financial health with steady revenue growth and improved profitability margins. The balance sheet remains robust with a stable equity base and manageable debt levels. However, the company faces challenges with negative free cash flow due to high capital expenditures, which need to be managed carefully.

Income Statement

The company has demonstrated consistent revenue growth over the past five years, with a revenue increase from ¥10,717 million in 2020 to ¥15,128 million in 2025. Gross profit margins have been stable, averaging around 20% over recent years, indicating efficient production and pricing strategies. Net profit margins have improved, particularly in the last two years, showing enhanced profitability and cost control. EBITDA margins have also strengthened, reflecting robust operating performance.

Balance Sheet

The balance sheet is strong with an improving equity position, as stockholders' equity has grown from ¥10,535 million in 2020 to ¥13,106 million in 2025. The debt-to-equity ratio has been stable, indicating manageable leverage levels. Return on equity has shown positive trends, suggesting efficient use of equity capital. However, the increasing total debt to ¥8,418 million warrants monitoring for potential leverage risks.

Cash Flow

Operating cash flow has been positive and growing, supporting the company's operational needs. However, free cash flow has been negative in recent years due to significant capital expenditures, which might indicate strategic investments or expansion. The operating cash flow to net income ratio is strong, showcasing good cash conversion efficiency, although consistent negative free cash flow could pose a challenge if not managed well.

Breakdown	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	15.13B	12.93B	12.84B	12.36B	11.09B
Gross Profit	3.23B	3.26B	3.05B	2.36B	1.82B
EBITDA	2.23B	1.88B	1.56B	1.18B	1.27B
Net Income	896.00M	776.00M	556.00M	248.00M	288.00M
Balance Sheet
Total Assets	26.87B	24.37B	22.12B	21.17B	21.00B
Cash, Cash Equivalents and Short-Term Investments	973.00M	588.00M	1.14B	1.86B	1.26B
Total Debt	8.42B	6.78B	5.58B	5.50B	6.10B
Total Liabilities	13.76B	11.94B	10.64B	10.17B	10.05B
Stockholders Equity	13.11B	12.43B	11.48B	11.00B	10.95B
Cash Flow
Free Cash Flow	-1.20B	-1.37B	-490.00M	1.40B	-208.00M
Operating Cash Flow	2.14B	388.00M	668.00M	1.79B	352.00M
Investing Cash Flow	-3.25B	-1.89B	-1.24B	-442.00M	-648.00M
Financing Cash Flow	1.50B	948.00M	-158.00M	-772.00M	106.00M

Yuki Gosei Kogyo Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 270.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4531, the sentiment is Positive. The current price of 270 is above the 20-day moving average (MA) of 265.65, above the 50-day MA of 265.20, and above the 200-day MA of 257.84, indicating a bullish trend. The MACD of 1.83 indicates Negative momentum. The RSI at 61.25 is Neutral, neither overbought nor oversold. The STOCH value of 90.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4531.

Yuki Gosei Kogyo Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4366	81 Outperform	¥8.93B	10.41		2.07%	13.02%	―
4531	73 Outperform	¥5.89B	8.22		3.33%	19.66%	-13.42%
4885	71 Outperform	¥2.75B	12.35		3.36%	4.46%	-27.53%
4960	69 Neutral	¥4.63B	32.33		1.24%	-5.30%	-6.24%
4040	65 Neutral	¥6.77B	6.58		1.89%	6.80%	-19.87%
4360	46 Neutral	¥5.06B	521.41		2.53%	1.73%	-914.83%
Sector *	44 Neutral	C$925.84M	-8.85	-0.23%	2.68%	24.44%	-41.96%

Yuki Gosei Kogyo Co., Ltd. Corporate Events

Yuki Gosei Kogyo Reports Increased Sales but Declining Profits in Q1 2025

Yuki Gosei Kogyo Co., Ltd. announced its non-consolidated financial results for the three months ended June 30, 2025, showing a significant increase in net sales by 22.4% compared to the previous year. However, the company experienced a decline in operating income, ordinary income, and net income by 55.8%, 61.2%, and 65.2% respectively, indicating challenges in maintaining profitability despite increased sales. The company maintains its dividend forecast for the fiscal year ending March 31, 2026, with no revisions, reflecting a cautious approach in its financial strategy.